BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2084603)

  • 1. [Evaluation of post-irradiation reaction in patients after radiotherapy of laryngeal cancer].
    Kozuch-Gdak W; Skołyszewski J; Gliński B; Kukolewska-Machnicka J; Semczuk L; Orzelski L; Wujec M; Peszyński J
    Otolaryngol Pol; 1990; 44(6):388-92. PubMed ID: 2084603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Post-irradiation reactions in patients with laryngeal cancer after continuous and intermittent Co-60 teletherapy].
    Peszyński J; Borowska B; Kozuch-Gdak W; Horoch A; Kupisz K
    Otolaryngol Pol; 1986; 40(6):409-13. PubMed ID: 3601396
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of early local post-irradiation reaction on total and protein-bound hydroxyproline levels in the blood and urine of patients with laryngeal cancer].
    Klonowski S; Klatka J
    Otolaryngol Pol; 1990; 44(6):380-3. PubMed ID: 2084601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local control and site of failure in radically irradiated supraglottic laryngeal cancer.
    Ghossein NA; Bataini JP; Ennuyer A; Stacey P; Krishnaswamy V
    Radiology; 1974 Jul; 112(1):187-92. PubMed ID: 4832491
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in hydroxyproline levels in the blood and urine of patients with laryngeal cancer after radiotherapy].
    Klatka J
    Otolaryngol Pol; 1990; 44(3):224-5. PubMed ID: 2255557
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of supraglottic cancer by radical high dose radiotherapy.
    Bataini JP; Ennuyer A; Poncet P; Ghossein NA
    Cancer; 1974 May; 33(5):1253-62. PubMed ID: 4207293
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiotherapy of laryngeal cancer. General principles and results in T1 and T2 cases.
    De Schryver A
    Acta Otorhinolaryngol Belg; 1992; 46(2):187-95. PubMed ID: 1605021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ionising rays and laryngeal carcinomas (author's transl)].
    Martin G; Glanz H; Kleinsasser O
    Laryngol Rhinol Otol (Stuttg); 1979 Mar; 58(3):187-95. PubMed ID: 374908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiogenic alterations following telecobalt irradiation of urinary bladder tumors].
    Kamprad F; Pfeiffer J
    Z Urol Nephrol; 1978 Aug; 71(8):541-6. PubMed ID: 726690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapeutic management of laryngeal carcinoma.
    Hristov B; Bajaj GK
    Otolaryngol Clin North Am; 2008 Aug; 41(4):715-40, vi. PubMed ID: 18570955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic discussions augmenting radiation effects and model systems.
    Bush RS; Hill RP
    Laryngoscope; 1975 Jul; 85(7):1119-33. PubMed ID: 807784
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromosome aberrations in patients treated with telecobalt therapy for glioblastoma.
    Léonard A; Decat G; Léonard ED; Lemaire M; Baugnet-Mahieu L
    Strahlenther Onkol; 1990 Jul; 166(7):466-9. PubMed ID: 2382209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lesions of the brachial plexus occurring after radiotherapy for cancer of the breast].
    Steiner C; Fallet GH; Moody JF; Roth G; Boussina I; Maurice PA; Alberto P; Paunier JP
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1846-8. PubMed ID: 5173502
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ultrastructure of the liver sinus following lethal and therapeutic roentgen irradiation].
    Frenzel H; Hücker H; Richter IE; Kremer B
    Verh Dtsch Ges Pathol; 1975; 59():565. PubMed ID: 1217132
    [No Abstract]   [Full Text] [Related]  

  • 15. Build-up and build-down measurements with thin LiF-teflon dosimeters with special reference to radiotherapy of carcinoma of the larynx.
    Koskinen MO; Spring E
    Strahlentherapie; 1973 May; 145(5):565-70. PubMed ID: 4761817
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radiation late damage of the thoracic marrow after irradiation in the thoracic region (author's transl)].
    Busse O; Wieland C; Egge M
    Med Klin; 1975 Feb; 70(9):385-91. PubMed ID: 1124051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Objectivization of the effectiveness of cobalt-60 teletherapy in female tumor patients].
    Michalica W; Klenkhart E; Kellner G
    Strahlentherapie; 1975 Oct; 150(4):375-9. PubMed ID: 1188996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiation therapy of stage III laryngeal cancer].
    Alferov VS; Ogol'tsova ES; Kondrat'eva AP
    Med Radiol (Mosk); 1989 Dec; 34(12):36-9. PubMed ID: 2601591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
    Inoue T; Inoue T; Teshima T; Murayama S; Yamazaki H; Nose T; Tanaka E
    Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
    Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
    Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.